Skip to content

Guardant Health

US · GH #820 by market cap Listed 2018
145.83 +0.24 +0.16%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Guardant Health

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Founded
2011
CEO
Mr. Helmy Eltoukhy
Employees
2,506
Headquarters
Palo Alto, California, United States of America
Fiscal year end
12-31
Website
guardanthealth.com

Company profile

Exchange
US
Symbol
GH
Market-cap rank
#820
Listing date
2018-10-04
Market cap
19.73B
Float cap
19.04B
Shares out
135.29M
Float shares
130.57M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Guardant Health discussion 0 comments

Add a comment